Lazard Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524K | Buy |
|
|||||
|
2025
Q1 | $441K | Sell |
|
|||||
|
2024
Q4 | $673K | Buy |
|
|||||
|
2024
Q3 | $462K | Buy |
|
|||||
|
2024
Q2 | $20K | Sell |
|
|||||
|
2024
Q1 | $66K | Sell |
|
|||||
|
2023
Q4 | $94K | Buy |
|
|||||
|
2023
Q3 | $83K | Buy |
|
|||||
|
2023
Q2 | $78K | Sell |
|
|||||
|
2023
Q1 | $416K | Buy |
|
|||||
|
2022
Q4 | $80K | Sell |
|
|||||
|
2022
Q3 | $174K | Buy |
|
|||||
|
2022
Q2 | $169K | Buy |
|
|||||
|
2022
Q1 | $153K | Sell |
|
|||||
|
2021
Q4 | $204K | Buy |
|
|||||
|
2021
Q3 | $116K | Sell |
|
|||||
|
2021
Q2 | $172K | Sell |
|
|||||
|
2021
Q1 | $545K | Buy |
|
|||||
|
2020
Q4 | $2K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.32M | Buy |
|
|||||
|
2019
Q4 | $8K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.74M | Buy |
|
|||||
|
2018
Q1 | $615K | Sell |
|
|||||
|
2017
Q4 | $830K | Sell |
|
|||||
|
2017
Q3 | $1.18M | Sell |
|
|||||
|
2017
Q2 | $1.51M | Sell |
|
|||||
|
2017
Q1 | $1.76M | Sell |
|
|||||
|
2016
Q4 | $2.56M | Sell |
|
|||||
|
2016
Q3 | $4.01M | Buy |
|
|||||
|
2016
Q2 | $2.77M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $384K | Buy |
|